Papers by Jurriën M. ten Berg
Page 3 · newest first
- Resumption of Antiplatelet Therapy after Major BleedingThrombosis and Haemostasis · 2022
- Cost-effectiveness of clopidogrel vs. ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndromeEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2022
- Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art reviewThrombosis Research · 2022
- External validation of the GRACE risk score and the risk–treatment paradox in patients with acute coronary syndromeOpen Heart · 2022
- Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testingResearch and Practice in Thrombosis and Haemostasis · 2021
- Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsEuropean Heart Journal · 2021
- Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patientsNetherlands Heart Journal · 2021
- COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarctionHeart · 2021
- Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemicDiabetes Epidemiology and Management · 2021
- Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countriesEuropean Heart Journal · 2021
- Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated PatientsJournal of Clinical Medicine · 2021
- Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse eventsNetherlands Heart Journal · 2021
- What Can We Learn from the Past by Means of Very Long-Term Follow-Up after Aortic Valve Replacement?Journal of Clinical Medicine · 2021
- Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi‐country observational studyClinical Cardiology · 2021
- Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment optionsNetherlands Heart Journal · 2021
- Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trialEuroIntervention · 2021
- Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarctionEuroIntervention · 2021
- The challenge of choosing in cardiovascular risk managementNetherlands Heart Journal · 2021
- Efficacy and safety of glycoproteinIIb/IIIainhibitors in addition toP2Y₁₂inhibitors inST‐segment elevation myocardial infarction: A subanalysis of thePOPularGenetics trialCatheterization and Cardiovascular Interventions · 2021
- 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevationNetherlands Heart Journal · 2021
- Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor RegistryBMC Cardiovascular Disorders · 2021
- Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndromeExpert Opinion on Drug Safety · 2021
- Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial NecrosisJournal of the American Heart Association · 2021
- VA-ECMO With IABP is Associated With Better Outcome Than VA-ECMO Alone in the Treatment of Cardiogenic Shock in ST-Elevation Myocardial InfarctionThe Journal of invasive cardiology/The journal of invasive cardiology · 2021
- Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐AnalysisJournal of the American Heart Association · 2021
- Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI TrialJACC: Cardiovascular Interventions · 2021
- Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio–FFR revascularization decision-making strategyScientific Reports · 2021
- Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registryBiomedicine & Pharmacotherapy · 2021
- Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseEuropean Heart Journal · 2021
- Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 GenotypeCirculation Cardiovascular Interventions · 2021
- Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies AheadThrombosis and Haemostasis · 2021
- Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)BJS Open · 2021
- Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathyInternational Journal of Cardiology · 2021
- The effect of transcatheter aortic valve implantation approaches on mortalityCatheterization and Cardiovascular Interventions · 2021
- NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trialAmerican Heart Journal · 2020
- Patient-tailored antithrombotic therapy following percutaneous coronary interventionEuropean Heart Journal · 2020
- Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCIEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2020
- How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018Netherlands Heart Journal · 2020
- Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age TrialJournal of Clinical Medicine · 2020
- Effect of aortic cross-clamp time on late survival after isolated aortic valve replacementInteractive Cardiovascular and Thoracic Surgery · 2020
- Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards “Personalized Medicine” in Daily Clinical PracticeJournal of Clinical Medicine · 2020
- Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across EuropeThe American Journal of Medicine · 2020
- Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General AnaesthesiaJournal of Interventional Cardiology · 2020
- Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG)Circulation · 2020
- Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve ImplantationNew England Journal of Medicine · 2020
- Association of Factor V Leiden With Subsequent Atherothrombotic EventsCirculation · 2020
- Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI TrialDrugs · 2020
- Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapyBMC Cardiovascular Disorders · 2020
- Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumClinical Pharmacology & Therapeutics · 2020
- External validation of existing prediction models of 30-day mortality after Transcatheter Aortic Valve Implantation (TAVI) in the Netherlands Heart RegistrationInternational Journal of Cardiology · 2020